User menu

Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.

Bibliographic reference Van den Bergh, Peter ; Francart, J. ; Mourin, S. ; Kollmann, P. ; Laterre, Emile-Christian. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.. In: Muscle & nerve, Vol. 18, no. 7, p. 720-9 (1995)
Permanent URL http://hdl.handle.net/2078.1/27779
  1. Biglan A. W., May M., Bowers R. A., Management of Facial Spasm With Clostridium botulinum Toxin, Type A (Oculinum), 10.1001/archotol.1988.01860240057024
  2. : Management of hemifacial spasm with botulinum A toxin, in (eds): Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994, pp 353-359.
  3. Blackie, J Neurol Neurosurg Psychiatry, 53, 640 (1990)
  4. Blitzer Andrew, Greene Paul E., Brin Mitchell F., Fahn Stanley, Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia, 10.1177/000348948909800202
  5. Boghen, Eur Neurol, 33, 199 (1993)
  6. Hemifacial spasm: evaluation and management, with emphasis on botulinum toxin therapy, in (eds): Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994, pp 331-351.
  7. Brin, Mov Dis, 2, 237 (1987)
  8. Brin, JRSM, 86, 493 (1993)
  9. : Oromandibular dystonia: treatment of 96 patients with botulinum toxin type A, in (eds): Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994, pp 429-435.
  10. Cohen L. G., Hallett M., Hand cramps: Clinical features and electromyographic patterns in a focal dystonia, 10.1212/wnl.38.7.1005
  11. Cohen, J Neurol Neurosurg Psychiatry, 52, 355 (1989)
  12. Cole, Neurology, 41, 291 (1991)
  13. Comella C. L., Buchman A. S., Tanner C. M., Brown-Toms N. C., Goetz C. G., Botulinum toxin injection for spasmodic torticollis: Increased magnitude of benefit with electromyographic assistance, 10.1212/wnl.42.4.878
  14. D'Costa, JRSM, 84, 650 (1991)
  15. Dubinsky, Clin Neuropharmacol, 12, 262 (1991)
  16. Duchen, J Neurol Sci, 14, 47 (1971)
  17. Dutton Jonathan J., Buckley Edward G., Long-term Results and Complications of Botulinum A Toxin in the Treatment of Blepharospasm, 10.1016/s0161-6420(88)32977-5
  18. Elston, J Neurol, 239, 5 (1992)
  19. Elston, Curr Med Lit Neurol Neurosurg, 9, 3 (1993)
  20. Engstrom Paul F., Arnoult Jeffrey B., Mazow Malcolm L., Prager Thomas C., Wilkins Robert B., Byrd William A., Hofmann R. Jeffrey, Effectiveness of Botulinum Toxin Therapy for Essential Blepharospasm, 10.1016/s0161-6420(87)33338-x
  21. Flanders, Eur Neurol, 33, 316 (1993)
  22. Gelb D. J., Lowenstein D. H., Aminoff M. J., Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis, 10.1212/wnl.39.1.80
  23. Greene P., Kang U., Fahn S., Brin M., Moskowitz C., Flaster E., Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis, 10.1212/wnl.40.8.1213
  24. Hermanowicz, Laryngoscope, 101, 1216 (1991)
  25. Jankovic J., Orman J., Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study, 10.1212/wnl.37.4.616
  26. Jankovic, J Neurol Neurosurg Psychiatry, 53, 633 (1990)
  27. Jankovic, N Engl J Med, 324, 1185 (1991)
  28. Jankovic J., Schwartz K. S., Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia, 10.1212/wnl.43.4.834
  29. Karp B. I., Cole R. A., Cohen L. G., Grill S., Lou J. S., Hallett M., Long-term botulinum toxin treatment of focal hand dystonia, 10.1212/wnl.44.1.70
  30. Lees, J Neurol, 239, 1 (1992)
  31. Lorentz, Mov Dis, 6, 145 (1991)
  32. Mauriello Joseph A., Coniaris Harry, Haupt Edward J., Use of BotuIinum Toxin in the Treatment of One Hundred Patients with Facial Dyskinesias, 10.1016/s0161-6420(87)33337-8
  33. Moore, J Neurol Neurosurg Psychiatry, 54, 813 (1991)
  34. Poewe, J Neurol, 239, 21 (1992)
  35. : Experience with botulinum toxin in cervical dystonia, in (eds): Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994, pp. 267-278.
  36. Quinn, Lancet, i, 964 (1989)
  37. Ruusuvaara, Acta Ophthalmol, 68, 331 (1990)
  38. Savino P. J., Sergott R. C., Bosley T. M., Schatz N. J., Hemifacial Spasm Treated With Botulinum A Toxin Injection, 10.1001/archopht.1985.01050090057031
  39. Saraux, J Fr Ophthalmol, 11, 237 (1988)
  40. : Preparation and characterization of botulinum toxin type A for human treatment, in (eds): Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994, pp 41-49.
  41. Scott A. B., Kennedy R. A., Stubbs H. A., Botulinum A Toxin Injection as a Treatment for Blepharospasm, 10.1001/archopht.1985.01050030043017
  42. Sheehy, Brain, 105, 461 (1982)
  43. Simpson, Ann Rev Pharmacol Toxicol, 26, 427 (1986)
  44. Stell, J Neurol Neurosurg Psychiatry, 51, 920 (1988)
  45. Taylor, Can J Ophthalmol, 26, 133 (1991)
  46. Assessment: The clinical usefulness of botulinum toxin-A in treating neurologic disorders, 10.1212/wnl.40.9.1332
  47. Tsui J.K., Eisen A., Mak E., Carruthers J., Scott A., Calne D.B., A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis, 10.1017/s031716710003540x
  48. Wissel, J Neural Transm, 38, 91 (1992)
  49. Yoshimura D. M., Aminoff M. J., Olney R. K., Botulinum toxin therapy for limb dystonias, 10.1212/wnl.42.3.627